AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16166579
Drug: tPA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tPA treatment
Trial: 27251051
Drug: Interferon beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a 30 mcg intramuscular once weekly
Trial: 23614998
Drug: Preexposure prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preexposure prophylaxis (PrEP) with daily tenofovir disoproxil fumarate/emtricitabine
Trial: 20092401
Drug: No vitamin
RxNorm normalized name: Vitamin B12 NOS
DrugBank: Cyanocobalamin (DB00115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No vitamin treatment (Group 1, n = 29)
Trial: 26965503
Drug: 80-kV protocol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 80-kV protocol B (PB; 1 g iodine/kg)
Trial: 23981616
Drug: Intracoronary bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary bolus of tirofiban (10 µg/kg)
Trial: 19079825
Drug: Critical comments
RxNorm normalized name: Critic-Aid Clear
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Critical comments (CC)
Trial: 10383527
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg b.d. in H. pylori-negative patients
Trial: 10383527
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg b.d. in H. pylori-positive patients
Trial: 1683355
Drug: Intravenous ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ribavirin therapy
Trial: 6662177
Drug: Piretanide 6
RxNorm normalized name: piretanide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 6 mg
Trial: 25435886
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH)
Trial: 2757878
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting propranolol 160 mg
Trial: 2757878
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting propranolol 80 mg
Trial: 19521532
Drug: Human PZQ
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human PZQ treatment only
Trial: 7572539
Drug: Immunotherapy (IT)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (IT)
Trial: 25163397
Drug: Everolimus plus
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus plus zoledronic acid (4 mg intravenously 4-weekly)
Trial: 25527749
Drug: Low-phenolic olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-phenolic olive oil (20 mL daily for 6 weeks)
Trial: 28663651
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg/4 ml
Trial: 8596489
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g glucose in 225 mL water (33.3% solution)
Trial: 31476924
Drug: Sulpiride 50
RxNorm normalized name: sulpiride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride 50 mg/d
Trial: 20492060
Drug: Antihypertensive medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive medicine (control group)
Trial: 16766594
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg L-AmB every other day (arm A)
Trial: 12205253
Drug: Early introduction
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early introduction of oral feeding (initiated 48 hours after achieving full tube feeding, 120 kcal/kg/d)
Trial: 12205253
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral feeding management left to discretion of attending physicians)
Trial: 17958901
Drug: PG-116800 25
RxNorm normalized name: PG
DrugBank: 1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (DB11331)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PG-116800 25 mg, taken twice daily for 12 months
Trial: 11716450
Drug: Pentoxifylline 200
RxNorm normalized name: pentoxifylline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 200 mg/day for 3 days in 500 ml of saline over 3‐4 hours
Trial: 27458234
Drug: Inhaled sodium
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled sodium nitrite (90 mg)
Trial: 24055176
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment satisfaction
Trial: 17095972
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (EA) with continuous infusion of fentanyl and bupivacaine for 2 days after VATS
Trial: 30311692
Drug: Percutaneous therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous therapy (PTNS) (30 min at 20 Hz and 200 cycles/s, once a week for 12 weeks)
Trial: 16778461
Drug: Miconazole nitrate
RxNorm normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole nitrate paste applied twice daily for 5 days at dosages of 1 and 2 mg/cm(2)
Trial: 12208795
Drug: Long-term simvastatin
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term simvastatin treatment
Trial: 27482615
Drug: Intravenous zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous zoledronic acid (ZOL) 5 mg once yearly
Trial: 12693324
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment only
Trial: 25842457
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel (FG) - 2% sodium fluoride
Trial: 6286118
Drug: Chemotherapy control
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy control group (adriamycin, vincristine, VP16‐213 and cyclophosphamide) without PIVN.
Trial: 28502503
Drug: Combined vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vitamin D (50,000 IU every 2 weeks) + omega-3 fatty acids (1000 mg twice a day)
Trial: 1728930
Drug: Serum cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum cholesterol levels above 4.65 mmol/L (180 mg/dL)
Trial: 16199428
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg/day
Trial: 24042367
Drug: Varenicline, 1
RxNorm normalized name: Varenicline, 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline, 1 mg twice daily for 12 weeks
Trial: 9741602
Drug: Phonophoresis (PH)
RxNorm normalized name: PH-284
DrugBank: PH-284 (DB05452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonophoresis (PH) with 0.05% fluocinonide gel
Trial: 17895943
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion therapy
Trial: 30987939
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (1000 mg once daily) plus prednisone (5 mg once daily) and ADT
Trial: 22908694
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate (FeSO₄) 100 mg
Trial: 22908694
Drug: Sodium iron
RxNorm normalized name: Sodium iron EDTA
DrugBank: Sodium feredetate (DB13381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium iron ethylenediaminetetraacetic acid (NaFeEDTA) 100 mg
Trial: 8921053
Drug: Purified follicle
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified follicle stimulating hormone (FSH, Metrodin High Purity) administered either i.m. (MHPim) or s.c. (MHPsc)
Trial: 2933998
Drug: Terbutaline 5
RxNorm normalized name: terbutaline 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 5 mg t.i.d.
Trial: 25186159
Drug: Pump therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pump therapy for 2 years
Trial: 29151374
Drug: SAF oil
RxNorm normalized name: SAF-GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAF oil with 6 mg lutein (FloraGLO 20%)
Trial: 12441211
Drug: lercanidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lercanidipine 10 mg/day
Trial: 12441211
Drug: amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amlodipine 5 mg/day
Trial: 31818847
Drug: Benzodiazepine administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzodiazepine administration
Trial: 30300282
Drug: 24-hour urinary
RxNorm normalized name: Urinary hCG
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour urinary creatinine excretion and TIMP‐2/mOsm on day 1
Trial: 23334069
Drug: Ponezumab 5
RxNorm normalized name: Ponezumab
DrugBank: Ponezumab (DB15135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponezumab 5 mg/kg
Trial: 23334069
Drug: Ponezumab 10
RxNorm normalized name: Ponezumab
DrugBank: Ponezumab (DB15135)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponezumab 10 mg/kg
Trial: 21062338
Drug: Traditional platform
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional platform implants (control group)
Trial: 19207079
Drug: Daptomycin monotherapy
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin monotherapy
Trial: 16678643
Drug: Acetaminophen 4
RxNorm normalized name: acetaminophen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 4 g/d
Trial: 12895183
Drug: Ciclopirox gel
RxNorm normalized name: Ciclopirox
DrugBank: Ciclopirox (DB01188)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclopirox gel 0.77% applied twice daily for 28 days
Trial: 1389821
Drug: Mixed infusions
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed infusions of propofol and alfentanil
Trial: 31198144
Drug: Protocol 1
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol 1 (55 mL iodinated contrast media)
Trial: 7856175
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg/day
Trial: 6981163
Drug: Low-dose trimethoprim
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose trimethoprim (TMP)
Trial: 23439942
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of natural honey
Trial: 12207597
Drug: Inpatient dithranol
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient dithranol treatment
Trial: 16546494
Drug: Oral medications
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medications (oral laxative, digestant, defoaming agent)
Trial: 24894651
Drug: EMD 1201081
RxNorm normalized name: Emdisterone
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMD 1201081 0.32 mg/kg subcutaneously weekly plus cetuximab (combination)
Trial: 19293071
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg
Trial: 15915935
Drug: Fenspiride treatment
RxNorm normalized name: fenspiride
DrugBank: Fenspiride (DB08979)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenspiride treatment for 3 months
Trial: 15915935
Drug: Fenspiride treatment
RxNorm normalized name: fenspiride
DrugBank: Fenspiride (DB08979)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenspiride treatment
Trial: 12373041
Drug: anti-Ox-LDL titer
RxNorm normalized name: OX BILE
DrugBank: Ox bile extract (DB14016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: anti-Ox-LDL titer on admission in patients who underwent thrombolytic therapy
Trial: 24308693
Drug: Porcilis PRRS
RxNorm normalized name: Torilis japonica whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porcilis PRRS vaccine
Trial: 12662126
Drug: Rituximab 375
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab 375 mg/m(2) intravenously plus CHOP chemotherapy
Trial: 30646422
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg
Trial: 29482528
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (metformin + saxagliptin)
Trial: 31352679
Drug: Prophylactic dose
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic dose of low-molecular-weight heparin
Trial: 7847131
Drug: Intrathecal tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal tissue plasminogen activator (rTPA) 10 mg in 10 ml solution, additional 5-10 mg for severe intraventricular bleeding
Trial: 535832
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate therapy
Trial: 29075917
Drug: Observational treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observational treatment strategy
Trial: 29075917
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment strategy
Trial: 11192133
Drug: Clarithromycin extended-release
RxNorm normalized name: Clarithromycin Extended-Release Tablets
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin extended-release
Trial: 2119446
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) with standard amino acids (1.5 g/kg/day)
Trial: 16782922
Drug: Black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh (Cimicifuga racemosa 20 mg BID)
Trial: 22278333
Drug: Telcagepant 600
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant 600 mg
Trial: 22278333
Drug: Telcagepant 900
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant 900 mg
Trial: 17378909
Drug: Pantoprazole 8
RxNorm normalized name: pantoprazole 80 MG in 100 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 8 mg/h continuous IV infusion for 48 h
Trial: 2700432
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg twice daily
Trial: 15055092
Drug: High-strength magnetic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-strength magnetic knee sleeve treatment
Trial: 9156046
Drug: Insulin tolerance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin tolerance test (0.15 U/kg body weight) in normal non-smokers
Trial: 19840579
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of clopidogrel (group I)
Trial: 1098594
Drug: Quinestrol 4
RxNorm normalized name: quinestrol 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinestrol 4 mg
Trial: 25989827
Drug: Reduced glutathione
RxNorm normalized name: Reduced glutathione
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced glutathione 1800 mg (n=416)
Trial: 21059094
Drug: Linagliptin 10
RxNorm normalized name: empagliflozin-linagliptin 10 mg-5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 10 mg
Trial: 27434084
Drug: β-alanine supplementation
RxNorm normalized name: Alanine
DrugBank: Alanine (DB00160)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-alanine supplementation (1.2 g·d during 5 weeks of SIT)
Trial: 30737835
Drug: Docetaxel with
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel with prednisone (5 mg twice daily for 3 cycles)
Trial: 20651615
Drug: Docetaxel monotherapy
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel monotherapy
Trial: 2981045
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone (hGH) 7 IU subcutaneously daily for 2 months, followed by salmon calcitonin (CT), 100 MRC units every other day for 3 months, repeated twice after a 3 month rest period
Trial: 2981045
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin (CT) given intermittently in the same time periods and at the same dose as in the coherence treatment group
Trial: 28128852
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg GLE + 120 mg PIB with 800 mg once-daily RBV (arm B)
Trial: 28128852
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg GLE + 120 mg PIB without RBV (arm C)
Trial: 3392240
Drug: Acebutolol 400
RxNorm normalized name: acebutolol 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 400 mg once daily
Trial: 31366980
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ascorbic acid
Trial: 18386621
Drug: Embryonary peptides
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embryonary peptides (EP) administered for 60 days
Trial: 411398
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (20 mg)
Trial: 3034062
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (100 micrograms patch)
Trial: 3034062
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (all doses)
Trial: 12053828
Drug: Various treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments for solar keratoses (specific interventions not detailed in the abstract)
Trial: 16729787
Drug: Budesonide aqueous
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide aqueous nasal spray, 64 microg (32 microg per nostril) once daily for 1 year
Trial: 11318767
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 microg once daily in the morning
Trial: 3503965
Drug: Serum physiologic
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum physiologic therapy
Trial: 3503965
Drug: Amoxicillin +
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin + antihistaminic + nose drops therapy
Trial: 16098233
Drug: Anti-HLA-DR antibody
RxNorm normalized name: Dr. Numb
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anti-HLA-DR antibody
Trial: 17882235
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light therapy for 4 weeks
Trial: 29907198
Drug: Daily soap
RxNorm normalized name: Santalia Daily Cleanser Soap Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily soap and water bathing